SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEKÂ 433.60
arrow_upward
+1.21%(+5.20) 1D
Oct 12, 5:29:36 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEKÂ 431.00
High
SEKÂ 435.40
Low
SEKÂ 430.00
Mkt. cap
155.07B
Avg. vol.
270.18K
Volume
188.77K
P/E ratio
115.81
52-wk high
SEKÂ 487.00
52-wk low
SEKÂ 293.60
EPS
SEKÂ 3.74
Shares outstanding
357.64M
No. of employees
2K
Open
SEKÂ 431.00
High
SEKÂ 435.40
Low
SEKÂ 430.00
Mkt. cap
155.07B
Avg. vol.
270.18K
Volume
188.77K
P/E ratio
115.81
52-wk high
SEKÂ 487.00
52-wk low
SEKÂ 293.60
EPS
SEKÂ 3.74
Shares outstanding
357.64M
No. of employees
2K
News stories
From web sources and news partners
Yahoo Finance
·
6 hours ago
Earnings Preview: Swedish Orphan Biovitrum (BIOVF) Q3 Earnings Expected to Decline
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)